AAAAAA

   
Results: 1-25 | 26-50 | 51-72
Results: 1-25/72

Authors: Serretti, A Zanardi, R Rossini, D Cusin, C Lilli, R Smeraldi, E
Citation: A. Serretti et al., Influence of tryptophan hydroxylase and serotonin transporter genes on fluvoxamine antidepressant activity, MOL PSYCHI, 6(5), 2001, pp. 586-592

Authors: Perez, J Tardito, D Racagni, G Smeraldi, E Zanardi, R
Citation: J. Perez et al., Protein kinase A and Rap1 levels in platelets of untreated patients with major depression, MOL PSYCHI, 6(1), 2001, pp. 44-49

Authors: Serretti, A Rietschel, M Lattuada, E Krauss, H Schulze, TG Muller, DJ Maier, W Smeraldi, E
Citation: A. Serretti et al., Major psychoses symptomatology: factor analysis of 2241 psychotic subjects, EUR ARCH PS, 251(4), 2001, pp. 193-198

Authors: Franchini, L Spagnolo, C Rossini, D Smeraldi, E Bellodi, L Politi, E
Citation: L. Franchini et al., A neural network approach to the outcome definition on first treatment with sertraline in a psychiatric population, ARTIF INT M, 23(3), 2001, pp. 239-248

Authors: Serretti, A Zanardi, R Cusin, C Rossini, D Lorenzi, C Smeraldi, E
Citation: A. Serretti et al., Tryptophan hydroxylase gene associated with paroxetine antidepressant activity, EUR NEUROPS, 11(5), 2001, pp. 375-380

Authors: Cavallaro, R Mistretta, P Cocchi, F Manzato, M Smeraldi, E
Citation: R. Cavallaro et al., Differential efficacy of risperidone versus haloperidol in psychopathological subtypes of subchronic schizophrenia, HUM PSYCHOP, 16(6), 2001, pp. 439-448

Authors: Zanardi, R Artigas, F Moresco, R Colombo, C Messa, C Gobbo, C Smeraldi, E Fazio, F
Citation: R. Zanardi et al., Increased 5-hydroxytryptamine-2 receptor binding in the frontal cortex of depressed patients responding to paroxetine treatment: A positron emission tomography scan study, J CL PSYCH, 21(1), 2001, pp. 53-58

Authors: Perna, G Bertani, A Caldirola, D Smeraldi, E Bellodi, L
Citation: G. Perna et al., A comparison of citalopram and paroxetine in the treatment of panic disorder: A randomized, single-blind study, PHARMACOPS, 34(3), 2001, pp. 85-90

Authors: Serretti, A Lilli, R Lorenzi, C Lattuada, E Cusin, C Smeraldi, E
Citation: A. Serretti et al., Tryptophan hydroxylase gene and major psychoses, PSYCHIAT R, 103(1), 2001, pp. 79-86

Authors: Benedetti, F Colombo, C Barbini, B Campori, E Smeraldi, E
Citation: F. Benedetti et al., Morning sunlight reduces length of hospitalization in bipolar depression, J AFFECT D, 62(3), 2001, pp. 221-223

Authors: Serretti, A Lilli, R Lorenzi, C Lattuada, E Smeraldi, E
Citation: A. Serretti et al., DRD4 exon 3 variants associated with delusional symptomatology in major psychoses: A study on 2,011 affected subjects, AM J MED G, 105(3), 2001, pp. 283-290

Authors: Cusin, C Serretti, A Lattuada, E Lilli, R Lorenzi, C Mandelli, L Pisati, E Smeraldi, E
Citation: C. Cusin et al., Influence of 5-HTTLPR and TPH variants on illness time course in mood disorders, J PSYCH RES, 35(4), 2001, pp. 217-223

Authors: Zanardi, R Serretti, A Rossini, D Franchini, L Cusin, C Lattuada, E Dotoli, D Smeraldi, E
Citation: R. Zanardi et al., Factors affecting fluvoxamine antidepressant activity: Influence of pindolol and 5-HTTLPR in delusional and nondelusional depression, BIOL PSYCHI, 50(5), 2001, pp. 323-330

Authors: Souery, D Van Gestel, S Massat, I Blairy, S Adolfsson, R Blackwood, D Del-Favero, J Dikeos, D Jakovljevic, M Kaneva, R Lattuada, E Lerer, B Lilli, L Milanova, V Muir, W Nothen, M Oruc, L Papadimitriou, G Propping, P Schulze, T Serretti, A Shapira, B Smeraldi, E Stefanis, C Thomson, M Van Broeckhoven, C Mendlewicz, J
Citation: D. Souery et al., Tryptophan hydroxylase polymorphism and suicidality in unipolar and bipolar affective disorders: A multicenter association study, BIOL PSYCHI, 49(5), 2001, pp. 405-409

Authors: Battaglia, M Bertella, S Ogliari, A Bellodi, L Smeraldi, E
Citation: M. Battaglia et al., Modulation by muscarinic antagonists of the response to carbon dioxide challenge in panic disorder, ARCH G PSYC, 58(2), 2001, pp. 114-119

Authors: Bellodi, L Cavallini, MC Bertelli, S Chiapparino, D Riboldi, C Smeraldi, E
Citation: L. Bellodi et al., Morbidity risk for obsessive-compulsive spectrum disorders in first-degreerelatives of patients with eating disorders, AM J PSYCHI, 158(4), 2001, pp. 563-569

Authors: Perez, J Tardito, D Mori, S Racagni, G Smeraldi, E Zanardi, R
Citation: J. Perez et al., Abnormalities of cAMP signaling in affective disorders: implications for pathophysiology and treatment, BIPOL DIS, 2(1), 2000, pp. 27-36

Authors: Serretti, A Lattuada, E Lorenzi, C Lilli, R Smeraldi, E
Citation: A. Serretti et al., Dopamine receptor D2 Ser/Cys 311 variant is associated with delusion and disorganization symptomatology in major psychoses, MOL PSYCHI, 5(3), 2000, pp. 270-274

Authors: Serretti, A Lattuada, E Franchini, L Smeraldi, E
Citation: A. Serretti et al., Melancholic features and response to lithium prophylaxis in mood disorders, DEPRESS ANX, 11(2), 2000, pp. 73-79

Authors: Moresco, RM Colombo, C Fazio, F Bonfanti, A Lucignani, G Messa, C Gobbo, C Galli, L Del Sole, A Lucca, A Smeraldi, E
Citation: Rm. Moresco et al., Effects of fluvoxamine treatment on the in vivo binding of [F-18]FESP in drug naive depressed patients: a pet study, NEUROIMAGE, 12(4), 2000, pp. 452-465

Authors: Serretti, A Lilli, R Lorenzi, C Smeraldi, E
Citation: A. Serretti et al., Further evidence supporting the association between the dopamine receptor D2 Ser/Cys311 variant and disorganized symptomatology of schizophrenia, SCHIZOPHR R, 43(2-3), 2000, pp. 161-162

Authors: Lucca, A Serretti, A Smeraldi, E
Citation: A. Lucca et al., Effect of reboxetine augmentation in SSRI resistant patients, HUM PSYCHOP, 15(2), 2000, pp. 143-145

Authors: Zanardi, R Benedetti, F Di Bella, D Catalano, M Smeraldi, E
Citation: R. Zanardi et al., Efficacy of paroxetine in depression is influenced by a functional polymorphism within the promoter of the serotonin transporter gene, J CL PSYCH, 20(1), 2000, pp. 105-107

Authors: Tzanakaki, M Guazzelli, M Nimatoudis, I Zissis, NP Smeraldi, E Rizzo, F
Citation: M. Tzanakaki et al., Increased remission rates with venlafaxine compared with fluoxetine in hospitalized patients with major depression and melancholia (vol 15, pg 29, 2000), INT CLIN PS, 15(2), 2000, pp. 120-120

Authors: Cusin, C Serretti, A Lattuada, E Mandelli, L Smeraldi, E
Citation: C. Cusin et al., Impact of clinical variables on illness time course in mood disorders, PSYCHIAT R, 97(2-3), 2000, pp. 217-227
Risultati: 1-25 | 26-50 | 51-72